"Roussel UCLAF: profits en hausse de 11%". l'Humanité. February 18, 1997. "Hoechst AG: Roussel Uclaf unit posts net profit increase of 90%". The Wall Street Journal. February 18, 1997. p. A6. 1996: $3.01 billion sales, $339.5 million net profit
lemonde.fr
Aizicovici, Francine (March 7, 1994). "Le désarroi des salariés". Le Monde. headquarters moved to Romainville in April 1995 after 40 years at 35 Boulevard des Invalides, Paris.
Eder, Richard (April 20, 1982). "Birth control: 4-day pill is promising in early test". The New York Times. p. C1. Herrmann, Walter; Wyss, Rolf; Riondel, Anne; Philibert, Daniel; Teutsch, Georges; Sakiz, Edouard; Baulieu, Étienne-Émile (May 17, 1982). "The effects of an antiprogesterone steroid in women: interruption of the menstrual cycle and of early pregnancy". Comptes Rendus de l'Académie des Sciences, Série III. 294 (18): 933–8. PMID6814714.
Smith, W. (September 1991). "Great Britain second country to allow use of RU-486". Plan Parent Eur. 20 (2): 20. PMID12284548.
"RU 486 licensed in Sweden". IPPF Med Bull. 26 (6): 6. December 1992. PMID12346922.
Eder, Richard (April 20, 1982). "Birth control: 4-day pill is promising in early test". The New York Times. p. C1. Herrmann, Walter; Wyss, Rolf; Riondel, Anne; Philibert, Daniel; Teutsch, Georges; Sakiz, Edouard; Baulieu, Étienne-Émile (May 17, 1982). "The effects of an antiprogesterone steroid in women: interruption of the menstrual cycle and of early pregnancy". Comptes Rendus de l'Académie des Sciences, Série III. 294 (18): 933–8. PMID6814714.
Newman, Barry (February 22, 1993). "Drug dilemma: among those wary of abortion pill is maker's parent firm; Germany's Hoechst is facing pressure from Clinton to sell RU-486 in U.S.". The Wall Street Journal. p. A1. "F.D.A. says company delays abortion pill". The New York Times. Associated Press. April 16, 1993. p. A14. Jouzaitis, Carol (October 17, 1994). "Abortion pill battle surprises French firm". Chicago Tribune. p. 1 (Business).
Moore, Stephen D.; Kamm, Thomas; Fleming, Charles (December 11, 1996). "Hoechst to seek rest of Roussel-Uclaf; expected $3.04 billion offer would add to the wave of drug-sector linkups". The Wall Street Journal. p. A3. Marshall, Matt (December 11, 1996). "Hoechst offers to pay $3.6 billion for rest of Roussel". The Wall Street Journal. p. A8. "Hoechst to buy rest of Roussel". The New York Times. Bloomberg Business News. December 11, 1996. p. D4.
Newman, Barry (February 22, 1993). "Drug dilemma: among those wary of abortion pill is maker's parent firm; Germany's Hoechst is facing pressure from Clinton to sell RU-486 in U.S.". The Wall Street Journal. p. A1. "F.D.A. says company delays abortion pill". The New York Times. Associated Press. April 16, 1993. p. A14. Jouzaitis, Carol (October 17, 1994). "Abortion pill battle surprises French firm". Chicago Tribune. p. 1 (Business).